VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
+21.66%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$141M
AUM Growth
+$141M
(+15%)
Cap. Flow
-$114M
Cap. Flow
% of AUM
-80.42%
Top 10 Holdings %
Top 10 Hldgs %
89.02%
Holding
34
New
5
Increased
3
Reduced
2
Closed
13
Top Buys
| 1 |
Tourmaline Bio
TRML
|
$8.35M |
| 2 |
Roivant Sciences
ROIV
|
$5.62M |
| 3 |
Aclaris Therapeutics
ACRS
|
$1.85M |
| 4 |
ADMA Biologics
ADMA
|
$1.81M |
| 5 |
Immunovant
IMVT
|
$1.16M |
Top Sells
| 1 |
Praxis Precision Medicines
PRAX
|
$108M |
| 2 |
QIPT
Quipt Home Medical
QIPT
|
$5.6M |
| 3 |
TELA Bio
TELA
|
$4.43M |
| 4 |
MoonLake Immunotherapeutics
MLTX
|
$3.15M |
| 5 |
Gossamer Bio
GOSS
|
$2.55M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALIM
1
DELISTED
Alimera Sciences, Inc.
ALIM
| $58.8M | 34.31% | 13,608,533 | – | – |
|
2
Heron Therapeutics
HRTX
$207M
| $11.9M | 6.93% | 6,986,744 | – | – |
|
|
3
ADMA Biologics
ADMA
$4.12B
| $9.66M | 5.64% | 2,136,100 +400,000 | +23% | +$1.81M |
|
4
Jasper Therapeutics
JSPR
$45.5M
| $8.55M | 4.99% | 11,219,036 | – | – |
|
|
5
Tourmaline Bio
TRML
$601M
| $8.35M | 4.88% | +319,080 | New | +$8.35M |
|
|
6
Praxis Precision Medicines
PRAX
$958M
| $7.7M | 4.5% | 345,666 -4,839,334 | -93% | -$108M |
|
|
IMGN
7
DELISTED
Immunogen Inc
IMGN
| $5.62M | 3.28% | 189,500 | – | – |
|
|
8
Roivant Sciences
ROIV
$8.15B
| $5.62M | 3.28% | +500,000 | New | +$5.62M |
|
|
OPTN
9
DELISTED
OptiNose
OPTN
| $4.9M | 2.86% | 3,796,861 +200,000 | +6% | +$258K |
|
10
Lantheus
LNTH
$3.73B
| $4.65M | 2.71% | 75,000 | – | – |
|
11
Inspire Medical Systems
INSP
$2.77B
| $3.66M | 2.14% | 18,000 +2,700 | +18% | +$549K |
|
12
Apellis Pharmaceuticals
APLS
$3.48B
| $2.99M | 1.75% | 50,000 | – | – |
|
13
InspireMD
NSPR
$102M
| $2.54M | 1.48% | 904,029 | – | – |
|
|
14
Aclaris Therapeutics
ACRS
$209M
| $1.85M | 1.08% | +1,761,595 | New | +$1.85M |
|
15
Geron
GERN
$893M
| $1.64M | 0.96% | 778,500 | – | – |
|
|
16
Immunovant
IMVT
$2.56B
| $1.16M | 0.68% | +27,500 | New | +$1.16M |
|
17
enVVeno Medical
NVNO
$15.4M
| $885K | 0.52% | +172,235 | New | +$885K |
|
|
18
TELA Bio
TELA
$70.5M
| $513K | 0.3% | 77,500 -668,587 | -90% | -$4.43M |
|
|
ELEV
19
DELISTED
Elevation Oncology
ELEV
| $267K | 0.16% | 497,299 | – | – |
|
20
InflaRx
IFRX
$108M
| – | – | -200,000 | Closed | -$596K |
|
21
Iovance Biotherapeutics
IOVA
$807M
| – | – | 0 | – | – |
|
22
iShares Russell 2000 ETF
IWM
$67B
| – | – | 0 | – | – |
|
|
23
MoonLake Immunotherapeutics
MLTX
$3.54B
| – | – | -55,300 | Closed | -$3.15M |
|
|
QIPT
24
Quipt Home Medical
QIPT
$114M
| – | – | -1,100,000 | Closed | -$5.6M |
|
25
Rezolute
RZLT
$619M
| – | – | -400,000 | Closed | -$528K |
|